Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients — Giulio Francesco Romiti (2021) | RDL Network
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients
Article 2021 en
Authors
GR
Giulio Francesco Romiti
BC
Bernadette Corica
EP
Eugenia Pipitone
Abstract
1 min read
COPD is common in AF, being found in 13% of patients, and is associated with increased burden of comorbidities, differential management, and worse outcomes, with more than a two-fold higher risk of all-cause death and increased risk of CV death and major bleeding. Therapy with BBs does not increase the risk of adverse outcomes in patients with AF and COPD.
Giulio Francesco Romiti, Bernadette Corica, Davide Antonio Mei, Freddy Frost, Arnaud Bisson, Giuseppe Boriani, Tommaso Bucci, Brian Olshansky, Tze‐Fan Chao, Menno V. Huisman, Marco Proietti, Professor Gregory Lip
Leanne Mooney, Pardeep S. Jhund, Inder S. Anand, Akshay S. Desai, Aldo Maggioni, Jean L. Rouleau, Karl Swedberg, Dirk J. van Veldhuisen, Michael R. Zile, Scott D. Solomon, John J.V. McMurray
Leanne Mooney, Nathaniel M. Hawkins, Pardeep S. Jhund, Margaret M. Redfield, Muthiah Vaduganathan, Akshay S. Desai, Jean L. Rouleau, Masatoshi Minamisawa, Amil M. Shah, Martin Lefkowitz, Michael R. Zile, Dirk J. van Veldhuisen, Marc A. Pfeffer, Inder S. Anand, Aldo Maggioni, Michele Senni, Brian Claggett, Scott D. Solomon, John J.V. McMurray
Discussion(0)
No comments yet. Be the first to comment.